A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised…
Tag: SSRIs
How FDA panelists casting doubt on antidepressant use during pregnancy could lead to devastating outcomes for mothers
At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective…
Timing of Prozac Treatment Shapes Lasting Mood, Brain Changes
Summary: New research reveals that the developmental timing of fluoxetine (Prozac) treatment profoundly influences long-term mood and brain function. In a rodent model, early postnatal treatment in males led to…
Antidepressants Impact Brain Development – Neuroscience News
Summary: Using antidepressants during pregnancy, specifically fluoxetine (found in Prozac and Sarafem), can significantly affect a child’s brain development, particularly in the prefrontal cortex, potentially increasing the risk of mental…
Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior
Summary: A new study found that treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) benefits not just mothers but also their children. The study, which analyzed data from over…
